Duchenne muscular dystrophy
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with a dystrophin abnormality proven by dystrophin gene testing or muscle pathology and a definitive diagnosis of DMD 2. Consent form for entry into the registry is available
Exclusion criteria
Exclusion criteria: 1. Consent form for entry into the registry is not available 2. Determined by investigators to be ineligible to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| none | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Time to Stand Test (TTSTAND) 2. Time to Run/Walk 10 Meters test (TTRW) 3. Brooke Upper Extremity Scale 4. North Star Ambulatory Assessment (NSAA) 5. Ambulate or not 6. Ventilator use 7. Wheelchair use 8. Cardiac function 9. Respiratory function 10. Medication used 11. QOL 12. Adverse Events | — |
Countries
Japan
Contacts
National Center of Neurology and Psychiatry Section of Clinical Research Support, Clinical Research and Education Promotion Division